Table 1.

Demographic and tumor characteristics of recruited participants.

	MP*1 (n = 21)	SP*2 (n = 21)	UC*31 (n = 20)
	N (%)	N (%)	N (%)
Race/Ethnicity
NH White	20 (95.2%)	18 (85.7%)	20 (100.0%)
H ispanic	0 (0.0%)	3 (14.3%)	0 (0.0%)
Asian	1 (4.8%)	0 (0.0%)	0 (0.0%)
Age Now
40–49.9	2 (9.5%)	1 (4.8%)	3 (15.0%)
50–59.9	6 (28.6%)	8 (38.1%)	9 (45.0%)
60–69.9	10 (47.6%)	10 (47.6%)	3 (15.0%)
70–79.9	3 (14.3%)	2 (9.5%)	5 (25.0%)
Age @ Invasive Breast Ca
40–49.9	3 (14.3%)	4 (19.0%)
50–59.9	7 (33.3%)	13 (61.9%)
60–69.9	8 (38.1%)	4 (19.0%)
70–79.9	3 (14.3%)	0 (0.0%)
Stage of Invasive Breast Ca
Localized	13 (61.9%)	14 (66.7%)
Lymph Nodes	6 (28.6%)	7 (33.3%)
Unknown	2 (9.5%)	0 (0.0%)
Histology of Invasive Breast Ca
Papillary Ca	1 (4.8%)	0 (0.0%)
Infiltrating Duct Ca	12 (57.1%)	17 (81.0%)
Lobular Ca	2 (9.5%)	2 (9.5%)
Duct./Lob. Ca	3 (14.3%)	2 (9.5%)
Infilt Duct W/Other Ca	3 (14.3%)	0 (0.0%)
Years bet Invasive Breast and Other Ca
0–4.9	7 (33.3%)
5–9.9	5 (23.8%)
10–14.9	8 (38.1%)
15–19.9	1 (4.8%)
Type Other Ca (5 have >1 other Ca)
Ovary	2 (7.7%)
Lung	2 (7.7%)
Breast	4 (15.4%)
Endometrium	5 (19.2%)
Thyroid	1 (3.8%)
Rectum	4 (15.4%)
Melanoma	5 (19.2%)
Lymph Nodes	2 (7.7%)
Kidney	1 (3.8%)

^*1Multiple primary,

^*2Single primary,

^*3Unaffected control.